FindTrial
Sign In

Valdecoxib 40 mg Type of group

2 trials

Sponsors

PFIZER S.A.,, PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,

Unknown Phase

Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily vs. Diclofenac 75 mg Twice Daily in Subjects With Acute Low Back Pain
Active, not recruitingPER-039-02
PFIZER S.A.,
Target: 4Updated: 2023-09-04
MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF PARALLEL GROUPS, TO COMPARE THE EFFECTIVENESS AND TOLERABILITY OF VALDECOXIB VS. DICLOFENACO IN THE ANKLE SPLINT
Active, not recruitingPER-063-02
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
Target: 20Updated: 2023-09-04